BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corbin IR, Ryner LN, Singh H, Minuk GY. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2004;287:G379-G384. [PMID: 15191882 DOI: 10.1152/ajpgi.00418.2003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Kotronen A, Yki-Järvinen H, Sevastianova K, Bergholm R, Hakkarainen A, Pietiläinen KH, Juurinen L, Lundbom N, Sørensen TI. Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity (Silver Spring). 2011;19:23-28. [PMID: 20539297 DOI: 10.1038/oby.2010.137] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
2 Bashir A, Gropler R, Ackerman J. Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient. PLoS One 2015;10:e0143239. [PMID: 26633549 DOI: 10.1371/journal.pone.0143239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chmelík M, Schmid AI, Gruber S, Szendroedi J, Krššák M, Trattnig S, Moser E, Roden M. Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31 P metabolites in human liver. Magn Reson Med 2008;60:796-802. [DOI: 10.1002/mrm.21762] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
4 Dagnelie PC, Leij-Halfwerk S. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J Gastroenterol 2010; 16(13): 1577-1586 [PMID: 20355236 DOI: 10.3748/wjg.v16.i13.1577] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khan V, Putluri N, Sreekumar A, Mindikoglu AL. Current Applications of Metabolomics in Cirrhosis. Metabolites 2018;8:E67. [PMID: 30360420 DOI: 10.3390/metabo8040067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Fritsch M, Koliaki C, Livingstone R, Phielix E, Bierwagen A, Meisinger M, Jelenik T, Strassburger K, Zimmermann S, Brockmann K, Wolff C, Hwang JH, Szendroedi J, Roden M. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients. Am J Clin Nutr 2015;102:1051-8. [PMID: 26423389 DOI: 10.3945/ajcn.115.107599] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
7 Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
8 Valkovič L, Chmelík M, Krššák M. In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism. Anal Biochem 2017;529:193-215. [PMID: 28119063 DOI: 10.1016/j.ab.2017.01.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
9 Margolis DJA, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. Molecular Imaging Techniques in Body Imaging. Radiology 2007;245:333-56. [DOI: 10.1148/radiol.2452061117] [Cited by in Crossref: 92] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
10 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
11 Osterode W, Falkenberg G, Höftberger R, Wrba F. Iron, copper, zinc and bromine mapping in cirrhotic liver slices from patients with hemochromatosis studied by microscopic synchrotron radiation X-ray fluorescence analysis in continuous scanning mode. Spectrochimica Acta Part B: Atomic Spectroscopy 2007;62:682-8. [DOI: 10.1016/j.sab.2007.03.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
12 Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X, Cai AJ, Dai Y. 1H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis. World J Gastroenterol 2012; 18(3): 285-290 [PMID: 22294833 DOI: 10.3748/wjg.v18.i3.285] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
13 Rastmanesh R, Marotta F, Kantah MK, Nagpal R, Lorenzetti A, Takadanohara H, Mashizume H, Kobayashi R, Chui de H. POLI-mix functional food enhances steady-state bioenergetic status independently of age: an experimental study. Rejuvenation Res 2012;15:161-4. [PMID: 22533423 DOI: 10.1089/rej.2011.1271] [Reference Citation Analysis]
14 Hughes-Cassidy F, Chavez AD, Schlang A, Hassanein T, Gamst A, Wolfson T, Sirlin C. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging. 2007;26:728-737. [PMID: 17685418 DOI: 10.1002/jmri.21066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
15 Jeon MJ, Lee Y, Ahn S, Lee C, Kim OH, Oh BC, Yu U, Kim H. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease. Acta Radiol 2015;56:1051-60. [PMID: 25270373 DOI: 10.1177/0284185114550850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Yu RS, Hao L, Dong F, Mao JS, Sun JZ, Chen Y, Lin M, Wang ZK, Ding WH. Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits. World J Gastroenterol 2009; 15(22): 2723-2730 [PMID: 19522022 DOI: 10.3748/wjg.15.2723] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Sharma R, Sinha S, Danishad K, Vikram NK, Gupta A, Ahuja V, Jagannathan N, Pandey R, Misra A. Investigation of hepatic gluconeogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo (31P) phosphorus magnetic resonance spectroscopy. Atherosclerosis 2009;203:291-7. [DOI: 10.1016/j.atherosclerosis.2008.06.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
18 Godfrey EM, Patterson AJ, Priest AN, Davies SE, Joubert I, Krishnan AS, Griffin N, Shaw AS, Alexander GJ, Allison ME, Griffiths WJH, Gimson AES, Lomas DJ. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 2012;22:2790-7. [DOI: 10.1007/s00330-012-2527-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
19 Landis CS, Zhou H, Liu L, Hetherington HP, Guha C. Liver regeneration and energetic changes in rats following hepatic radiation therapy and hepatocyte transplantation by ³¹P MRSI. Liver Int 2015;35:1145-51. [PMID: 25775097 DOI: 10.1111/liv.12507] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Godfrey EM, Mannelli L, Griffin N, Lomas DJ. Magnetic resonance elastography in the diagnosis of hepatic fibrosis. Semin Ultrasound CT MR. 2013;34:81-88. [PMID: 23395320 DOI: 10.1053/j.sult.2012.11.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
21 Laufs A, Livingstone R, Nowotny B, Nowotny P, Wickrath F, Giani G, Bunke J, Roden M, Hwang J. Quantitative liver 31 P magnetic resonance spectroscopy at 3T on a clinical scanner: Quantitative Liver 31 P MR Spectroscopy on a 3T Clinical Scanner. Magn Reson Med 2014;71:1670-5. [DOI: 10.1002/mrm.24835] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
22 Zhu XL, Du YZ, Yu RS, Liu P, Shi D, Chen Y, Wang Y, Huang FF. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate. Int J Mol Sci. 2013;14:15755-15766. [PMID: 23899789 DOI: 10.3390/ijm5140815755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 De Robertis R, D’Onofrio M, Demozzi E, Crosara S, Canestrini S, Pozzi Mucelli R. Noninvasive diagnosis of cirrhosis: A review of different imaging modalities. World J Gastroenterol 2014; 20(23): 7231-7241 [PMID: 24966594 DOI: 10.3748/wjg.v20.i23.7231] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
24 Mckenzie EJ, Jackson M, Sun J, Volotovskyy V, Gruwel ML. Monitoring the development of hepatocellular carcinoma in woodchucks using 31P-MRS. MAGMA 2005;18:201-5. [DOI: 10.1007/s10334-005-0120-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Zhu XL, Du YZ, Yu RS, Liu P, Shi D, Chen Y, Wang Y, Huang FF. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate. Int J Mol Sci 2013;14:15755-66. [PMID: 23899789 DOI: 10.3390/ijms140815755] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
26 Yu RS, Zhu XL, Sun JZ, Shi D, Chen Y, Wang ZK, Tang KZ, Du YZ. Preliminary Study on Hepatocyte-Targeted Phosphorus-31 MRS Using ATP-Loaded Galactosylated Chitosan Oligosaccharide Nanoparticles. Gastroenterol Res Pract 2013;2013:512483. [PMID: 24363667 DOI: 10.1155/2013/512483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]